Concepedia

Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activity

Meisam Naeimi Kararoudi, Brian P. Tullius, Nitin Chakravarti, Emily J. Pomeroy, Branden S. Moriarity, Kathie Béland, A. Colamartino, Élie Haddad, Yaya Chu, Mitchell S. Cairo,

Seminars in Hematology · 2020 · 21 citations · 84 references

DOIFull text

Open access

Concepts

References

84

Genome engineering using the CRISPR-Cas9 system

F. Ann Ran, Patrick D. Hsu, Jason Wright et al. · Nature Protocols · 2013 · 11.7K citations · Full text

, , +14

<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1

S. Hacein-Bey-Abina, Christof von Kalle, Manfred Schmidt et al. · Science · 2003 · 3.6K citations

, , +17

Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA

Luigi Warren, Philip D. Manos, Tim Ahfeldt et al. · Cell stem cell · 2010 · 2.6K citations · Full text

, , +17

Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease

Marina Cavazzana, Salima Hacein‐Bey, Geneviève de Saint Basile et al. · Science · 2000 · 2.6K citations

, , +17

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

Enli Liu, David Marín, Pinaki P. Banerjee et al. · New England Journal of Medicine · 2020 · 2.1K citations · Full text

, , +17